Joël Lightbound, Member of Parliament for Louis-Hébert and Parliamentary Secretary to the Minister of Finance, acting on behalf of the Honourable Navdeep Bains, Minister of Innovation, Science and Economic Development and Minister responsible for Canada Economic Development for Quebec Regions (CED), and Sébastien Proulx, Member for Jean-Talon, Minister of Education, Recreation and Sports and Minister responsible for the Capitale-Nationale region, acting on behalf of Dominique Anglade, Deputy Premier, Minister of Economy, Science and Innovation and Minister responsible for the Digital Strategy, are inviting you to a press conference on Les produits PolarMade Inc.
Please note that Rémy Normand, Vice-Chair of the Executive Committee and President of the Borough of Sainte-Foy?Sillery?Cap-Rouge, will be speaking on behalf of Régis Labeaume, Mayor of Québec City.
The dignitaries and the media will be invited to visit the company's facilities following the formalities.
Date:
Friday, August 17, 2018
Time:
8:30 a.m.
Location:
Les produits PolarMade Inc. 2811 Watt Avenue, Room 106 Québec City, Quebec G1X 4S8
The company's office is on the left side of the building.
SOURCE Canada Economic Development for Quebec Regions
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New...
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...